News | November 30, 2010

BSGI/MBI Gains Recognition in Breast Cancer Detection and Diagnosis

November 30, 2010 - Breast-Specific Gamma Imaging/Molecular Breast Imaging (BSGI/MBI) is gaining momentum as a standard of care in the diagnostic work up of patients. Several presentations at the 2010 Radiological Society of North America (RSNA) meeting will also show how the technology is an important diagnostic tool for early breast cancer detection.

Additionally, the Society of Nuclear Medicine (SNM) recently released a nuclear medicine breast imaging protocol that includes specific procedural guidelines and clinical indications for conducting BSGI/MBI.

BSGI/MBI is especially useful in difficult-to-diagnose cases such as ductal carcinoma in situ (DCIS), where mammography may not accurately display the extent of the disease. At RSNA researchers will demonstrate the sensitivity of BSGI for DCIS to be 93 percent to 95 percent for determining the extent of disease and varying pathological parameters.

“BSGI is a valuable tool that improves diagnostic accuracy, and complements other modalities, when included in the breast imaging protocol,” said Jocelyn A. Rapelyea, M.D., associate professor of radiology, George Washington University. “This modality is especially effective in assessing the extent of disease and assisting in surgical planning.”

The investigators of another study will demonstrate that BSGI is a useful tool for improving the detection of malignancies. They will also note that the physiological information of BSGI is complementary to the anatomical depiction of the breast by mammography and ultrasound.

The SNM Guidelines
In June 2010 the Society of Nuclear Medicine (SNM) released a nuclear medicine breast imaging protocol, The SNM Procedure Guideline for Breast Scintigraphy with Breast-Specific Gamma Cameras. This protocol includes specific guidelines for conducting BSGI and helps improve the understanding of how and when to use molecular breast imaging in patient care. For a complete review of the new SNM protocol for BSGI/MBI go to http://interactive.snm.org/docs/Breast_v2.0.pdf.

BSGI utilizes the Dilon 6800 Gamma Camera to help physicians differentiate benign from malignant tissue. To perform BSGI, the patient receives a pharmaceutical tracing agent that is absorbed by all the cells in the body. Due to their increased rate of metabolic activity, cancerous cells in the breast absorb a greater amount of the tracing agent than normal, healthy cells and generally appear as dark spots on the BSGI image.

For more information: www.dilon.com.

Related Content

ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging | August 18, 2017
August 18, 2017 — The American Society of Nuclear Cardiology (ASNC) has released a joint expert consensus document wi
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Imaging | August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Study Demonstrates First Human Application of Novel PET Tracer for Prostate Cancer

Transaxial 11Csarcosine hybrid PET/CT showed a (triangulated) adenocarcinoma in the transition zone of the anterior right prostate gland on PET (A), CT (B), and a separately obtained T2?weighted MR sequence (C) with resulting PET/MRI registration (D). Image courtesy of M. Piert et al., University of Michigan, Ann Arbor, Mich.

News | Radiopharmaceuticals and Tracers | August 16, 2017
In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the...
MRI Reveals Striking Brain Differences in People with Genetic Autism

Example images for a control participant , a deletion carrier, and a duplication carrier. In the sagittal image of the deletion carrier, the thick corpus callosum, dens and craniocervical abnormality, and cerebellar ectopia are shown. For the duplication carrier, the sagittal image shows the thin corpus callosum and the axial image shows the increased ventricle size and decreased white matter volume. Image courtesy of the Radiological Society of North America (RSNA).

News | Neuro Imaging | August 09, 2017
August 9, 2017 — In the first major study of its kind, researchers using magnetic...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
brain with chronic traumatic injury
News | Magnetic Resonance Imaging (MRI) | August 02, 2017
Fighters are exposed to repeated mild traumatic brain injury (mTBI), which has been associated with neurodegenerative...
NIH-funded scientists have discovered that Parkinson’s disease increases the amount of “free” water in a particular brain area

NIH-funded scientists have discovered that Parkinson’s disease increases the amount of “free” water in a particular brain area. Image courtesy of David Vaillancourt, Ph.D., University of Florida.

News | Neuro Imaging | July 31, 2017
Scientists at the University of Florida have discovered a new method of observing the brain changes caused by Parkinson...
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
Overlay Init